| Date: 2021/08/20 | File Size: 380.36 MB |
| Duration: 00:02:55 | Frame Size: 1920 x 1080 |
The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of the monoclonal antibody treatment for COVID-19 developed by Regeneron Pharmaceuticals and F. Hoffmann-La Roche AG.